Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is planned to evaluate Lactiplantibacillus plantarum 299v probiotic supplementation in patients with diabetic macular edema; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactiplantibacillus plantarum 299v (Lactiplantibacillus plantarum 299v)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Diabetic Macular Edema | Phase 2 | Status: NOT_YET_RECRUITING